Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rai

Showing results (501-510 of 543) with videos related to

Pageof 55
Sort By:
Blood|March 16, 2018
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLLMichael Hallek, Bruce D Cheson, Daniel Catovsky, et al.
Cancer Genetics and Cytogenetics|December 16, 2010
Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL Research Consortium (CRC) StudyNyla A Heerema, John C Byrd, Paola S Dal Cin, et al.
Blood|March 10, 2011
A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the diseaseDavide Bagnara, Matthew S Kaufman, Carlo Calissano, et al.
Blood Advances|January 4, 2018
Combinations of idelalisib with rituximab and/or bendamustine in patients with recurrent indolent non-Hodgkin lymphomaSven de Vos, Nina D Wagner-Johnston, Steven E Coutre, et al.
Blood|November 6, 2016
High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemiaBing Cui, Emanuela M Ghia, Liguang Chen, et al.
Frontiers in Oncology|June 11, 2021
Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical CourseDavide Bagnara, Catherine Tang, Jennifer R Brown, et al.
Experimental Hematology|January 9, 2021
Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemiaGonzalo Blanco, Anna Puiggros, Barbara Sherry, et al.
Blood|October 17, 2012
IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functionsPiers E M Patten, Charles C Chu, Emilia Albesiano, et al.
Journal of Medicinal Chemistry|August 10, 2001
Development of serine protease inhibitors displaying a multicentered short (<2.3 A) hydrogen bond binding mode: inhibitors of urokinase-type plasminogen activator and factor XaE Verner, B A Katz, J R Spencer, et al.
Haematologica|November 13, 2012
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studiesAlessandra Cesano, Omar Perbellini, Erik Evensen, et al.
Pageof 55

Showing results (501-510 of 543) with videos related to

Sort By:
Pageof 55
Blood|March 16, 2018
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLLMichael Hallek, Bruce D Cheson, Daniel Catovsky, et al.
Cancer Genetics and Cytogenetics|December 16, 2010
Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL Research Consortium (CRC) StudyNyla A Heerema, John C Byrd, Paola S Dal Cin, et al.
Blood|March 10, 2011
A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the diseaseDavide Bagnara, Matthew S Kaufman, Carlo Calissano, et al.
Blood Advances|January 4, 2018
Combinations of idelalisib with rituximab and/or bendamustine in patients with recurrent indolent non-Hodgkin lymphomaSven de Vos, Nina D Wagner-Johnston, Steven E Coutre, et al.
Blood|November 6, 2016
High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemiaBing Cui, Emanuela M Ghia, Liguang Chen, et al.
Frontiers in Oncology|June 11, 2021
Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical CourseDavide Bagnara, Catherine Tang, Jennifer R Brown, et al.
Experimental Hematology|January 9, 2021
Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemiaGonzalo Blanco, Anna Puiggros, Barbara Sherry, et al.
Blood|October 17, 2012
IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functionsPiers E M Patten, Charles C Chu, Emilia Albesiano, et al.
Journal of Medicinal Chemistry|August 10, 2001
Development of serine protease inhibitors displaying a multicentered short (<2.3 A) hydrogen bond binding mode: inhibitors of urokinase-type plasminogen activator and factor XaE Verner, B A Katz, J R Spencer, et al.
Haematologica|November 13, 2012
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studiesAlessandra Cesano, Omar Perbellini, Erik Evensen, et al.
Pageof 55